跳至主要内容
临床试验/IRCT20140804018677N14
IRCT20140804018677N14招募中未知

Investigating the effect of nano formulation of crocin from saffron in comparison with placebo on cognitive function, plasma level of total antioxidant capacity, malondialdehyde and glutathione reductase in plasma of patients with relapsing-remitting multiple sclerosis: A randomized triple blinded clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • The desire of the person to participate in the study
  • Definite dagnosis of relapsing-remitting MS based on the 2017 McDonald Diagnostic Criteria
  • Age range 55-18 years
  • EDSS less than 5.5
  • Education higher than diploma
  • More than a month has passed since the last injection of corticosteroids (pulse therapy)
  • More than a month has passed since the last recurrence of the disease

排除标准

  • Having a neurological disease other than MS
  • Pregnancy or breastfeeding
  • Suffering from chronic gastrointestinal, liver, kidney, heart, respiratory and cancer diseases
  • Being on a special diet
  • Suffering from severe psychological disorders such as major depression
  • History of allergies to saffron or its compounds

研究者

相似试验